EE59 Economic Evaluation of Dapagliflozin for the Treatment of Patients with Heart Failure and Reduced Ejection Fraction in Mexico

Abstract

Authors

M Carmona MP Buritica

Full Text Cite This Article
Back to Volume 25, Supplemental Issue 7S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×